title: Effects of nimodipine on posttraumatic spinal cord ischemia in baboons.
abstract: Posttraumatic ischemia appears to be largely responsible for the extension of lesions in acute injury of the spinal cord. In the present study, we have evaluated the putative improvement of axonal function by the calcium channel blocker nimodipine after acute trauma of the spinal cord. Three techniques were used: (1) spinal cord blood flow (SCBF) using a scanographic technique with stable xenon, (2) somatosensory evoked potentials (SEPs), and (3) magnetic resonance imaging (MRI). Thirteen baboons were used in this study. Acute trauma was achieved by compression of the spinal cord at level L1 by applying pressure for 5 sec with an inflated balloon catheter injected with Ringer's solution. Following the injury, one group (n = 5) received a saline infusion (placebo) for seven days, and a second group (n = 8) received a nimodipine infusion (0.04 mg/kg/h) during the same period of time. SCBF and SEP were first recorded prior to trauma. SCBF, SEPs, and MRI were then recorded on the day of the injury and eight days prior to histologic examination of the spinal cord. In these studies nimodipine significantly improved SCBF. The decrease in SCBF observed at day one and day eight following trauma was significantly reduced in the treated group. Two baboons in the treated group also showed improvement of axonal function as assessed by SEP. No significant difference was observed with MRI, however, histologic study revealed that the lesions were significantly smaller in the treated group. Based on these observations we conclude that a week of nimodipine treatment following spinal cord injury enhances SCBF, limits the size of the spinal cord lesion, and perhaps improves functional recovery.
authors.affiliation: Unité de Pathologie Rachidienne, Hôpital Pellegrin, Bordeaux, France.
authors.forename: V
authors.initials: V
authors.lastname: Pointillart
authors.forename: D
authors.initials: D
authors.lastname: Gense
authors.forename: C
authors.initials: C
authors.lastname: Gross
authors.forename: A M
authors.initials: AM
authors.lastname: Bidabé
authors.forename: A M
authors.initials: AM
authors.lastname: Gin
authors.forename: J
authors.initials: J
authors.lastname: Rivel
authors.forename: J M
authors.initials: JM
authors.lastname: Caillé
authors.forename: J
authors.initials: J
authors.lastname: Sénégas
mesh_terms: D000818:Animals; D001794:Blood Pressure / Q000502:physiology; D005073:Evoked Potentials, Somatosensory / Q000187:drug effects; D008279:Magnetic Resonance Imaging; D009553:Nimodipine / Q000627:therapeutic use*; D010215:Papio; D012039:Regional Blood Flow / Q000187:drug effects; D013116:Spinal Cord / Q000098:blood supply; D013119:Spinal Cord Injuries / Q000188:drug therapy* / Q000473:pathology / Q000503:physiopathology; D014057:Tomography, X-Ray Computed
chemical_list: D009553:Nimodipine